Close

News

La Jolla Pharmaceutical Company to Acquire Tetraphase Pharmaceuticals

La Jolla Pharmaceutical Company, which is dedicated to the development and commercialization of innovative therapies that improve outcomes in patients suffering from life-threatening diseases, and Tetraphase Pharmaceuticals, Inc. (Nasdaq: TTPH), a biopharmaceutical company focused on commercializing its novel tetracycline...

Avid Bioservices Names Nicholas Green as President and Chief Executive Officer

Avid Bioservices, Inc., a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, announced that Nicholas Green has been appointed president and...

Zealand Pharma announces first patient dosed in Phase 2 trial with long-acting GLP-1 dual agonist in obesity/diabetes

Zealand Pharma announced that the first patient has been dosed in a Phase 2 clinical trial of the long-acting GLP-1/glucagon dual agonist BI 456906, which Zealand has licensed to Boehringer Ingelheim. As part of the license agreement, Zealand will...

EPG Health launches Medthority, a medical website personalised for doctors and tailored for pharma

When providing medical information online, enhanced user experience (UX) is the key to delivering real according to digital medical publisher EPG Health. Such is their reason for launching Medthority (www.medthority.com), to replace the company’s previous website for healthcare professionals...

Piramal Pharma Announces Acquisition of Solid Oral Dosage Drug Product Facility in Pennsylvania from G&W Laboratories

Piramal Enterprises Limited’s (PEL) Pharma Solutions business, a contract development and manufacturing organization, has entered into an agreement with G&W Laboratories Inc. to acquire its solid oral dosage drug product manufacturing facility located in Sellersville, PA. According to the...

Gemini Bio opens new manufacturing facility in West Sacramento, California

Gemini Bioproducts, LLC, a leading supplier of cell culture reagents and a portfolio company of BelHealth Investment Partners, LLC, a New York-based healthcare private equity firm,  announced the opening of a new, state-of-the-art manufacturing facility in West Sacramento, California. Gemini...

WuXi NextCODE Restructures and Becomes Genuity Science

WuXi NextCODE announced plans to restructure its operations and governance in order to best position the company for future growth, ground-breaking offerings for customers, and new collaborations with industry partners. As part of these efforts, effective June 23, 2020,...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read